Page last updated: 2024-08-16

ribavirin and Diabetes Mellitus

ribavirin has been researched along with Diabetes Mellitus in 19 studies

Research

Studies (19)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	9 (47.37)	29.6817
2010's	9 (47.37)	24.3611
2020's	1 (5.26)	2.80

Authors

Authors	Studies
Abdel-Razik, A; El-Wakeel, N; Eldars, W; Elgamal, A; Elkashef, W; Elzehery, R; Farag, R; Mousa, N; Shabana, W	1
Chang, KC; Chen, CH; Hu, TH; Hung, CH; Kuo, FY; Lin, JT; Lin, MT; Lu, SN; Tsai, MC; Tseng, PL; Wang, JH; Wu, CK; Yen, YH	1
Furqan, S; Jabeen, S; Rashid, O	1
Abou-Samra, AB; Aslam, S; Butt, AA; Shaikh, OS; Yan, P	1
Ho, HJ; Hsiao, NW; Hsu, YC; Huang, YT; Kao, YH; Lin, JT; Liu, YY; Wu, CY; Wu, MS	1
Kobayashi, T	1
Al-Tawfiq, JA; Dib, J; Memish, ZA; Momattin, H	1
Bugianesi, E; Saracco, GM; Vanni, E	1
Elgouhari, HM; Feldstein, AE; Hanouneh, I; Zein, CO; Zein, NN	1
Cammà, C; Petta, S	1
Gilani, N; Panetta, JD	1
Abderrahim, E; Ben Abdallah, T; Ben Hamida, F; Ben Maïz, H; Bezzine, H; Hedri, H; Khaled, S; Kheder, A; Ounissi, M; Trabelsi, S	1
Abdo, AA; Ahmed, LR; Al-hamoudi, W; Al-Husseini, H; Al-Otaibi, MM; Albenmousa, A; Ali, SM; AlQaraawi, AM; AlSheikh, A; Alswat, KA; Hersi, A; Sanai, FM; Syed, M	1
Abdel-Aziz, A; Besheer, T; Elbendary, A; Gad, Y; Mokbel, T; Mousa, N	1
del Mar Alcalde, M; Jiménez, C; Narváez, I; Pérez, B; Soria, A	1
Hsieh, CH; Tasi, TN	1
Bräu, N; Eldeiry, LS; Greenberg, PD; Naqvi, Z; Rosman, AS	1
Bonkovsky, HL; Chung, RT; Di Bisceglie, AM; Everhart, JE; Everson, GT; Ghany, MG; Greenson, JK; Lee, WM; Lindsay, KL; Lok, AS; Morgan, TR; Morishima, C; Padmanabhan, L; Shiffman, ML	1
Robertson, M	1

Trials

2 trial(s) available for ribavirin and Diabetes Mellitus

Article	Year
Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients. Hepatology (Baltimore, Md.), 2014, Volume: 59, Issue:4 Topics: Acute Coronary Syndrome; Adult; Aged; Antiviral Agents; Cohort Studies; Comorbidity; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Humans; Incidence; Interferon-alpha; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Stroke; Taiwan; Treatment Outcome	2014
Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2007, Volume: 5, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Diabetes Mellitus; Disease Progression; Fatty Liver; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Prevalence; Prospective Studies; Recombinant Proteins; Ribavirin; Risk Factors	2007

Article

Year

Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients.

Hepatology (Baltimore, Md.), 2014, Volume: 59, Issue:4

Topics: Acute Coronary Syndrome; Adult; Aged; Antiviral Agents; Cohort Studies; Comorbidity; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Humans; Incidence; Interferon-alpha; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Stroke; Taiwan; Treatment Outcome

2014

Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2007, Volume: 5, Issue:2

Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Diabetes Mellitus; Disease Progression; Fatty Liver; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Prevalence; Prospective Studies; Recombinant Proteins; Ribavirin; Risk Factors

2007

Other Studies

17 other study(ies) available for ribavirin and Diabetes Mellitus

Article	Year
Do we need to screen for de-novo diabetes mellitus in chronic hepatitis C patients after a sustained virological response? European journal of gastroenterology & hepatology, 2017, Volume: 29, Issue:9 Topics: Adult; Antiviral Agents; Biomarkers; Blood Glucose; Body Mass Index; Diabetes Mellitus; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Insulin; Insulin Resistance; Interferon alpha-2; Interferon-alpha; Leptin; Male; Middle Aged; Polyethylene Glycols; Predictive Value of Tests; Prospective Studies; Recombinant Proteins; Ribavirin; Risk Factors; Sustained Virologic Response; Time Factors; Treatment Outcome	2017
The association between steatosis and diabetes with hepatocellular carcinoma in non-genotype 3 chronic hepatitis C patients. Liver international : official journal of the International Association for the Study of the Liver, 2018, Volume: 38, Issue:6 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Diabetes Complications; Diabetes Mellitus; Fatty Liver; Female; Genotype; Hepatitis C, Chronic; Humans; Interferons; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Retrospective Studies; Ribavirin; Risk Factors; Sustained Virologic Response; Taiwan	2018
Sofosbuvir Causing Diabetes Mellitus: Is there a Link? Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2018, Volume: 28, Issue:5 Topics: Antiviral Agents; Benzimidazoles; Blood Glucose; Carbamates; Diabetes Mellitus; Drug Therapy, Combination; Female; Glycated Hemoglobin; Hepatitis C, Chronic; Humans; Imidazoles; Middle Aged; Pyrrolidines; Ribavirin; Sofosbuvir; Treatment Outcome; Valine	2018
Hepatitis C Virus (HCV) Treatment With Directly Acting Agents Reduces the Risk of Incident Diabetes: Results From Electronically Retrieved Cohort of HCV Infected Veterans (ERCHIVES). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 03-03, Volume: 70, Issue:6 Topics: Antiviral Agents; Diabetes Mellitus; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Ribavirin; Treatment Outcome; Veterans	2020
[Comparative study of the time period between the initiation of various interferon therapies and the onset of suicide- or diabetes-related side effect]. Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo hokoku = Bulletin of National Institute of Health Sciences, 2013, Issue:131 Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Databases, Pharmaceutical; Diabetes Mellitus; Drug Therapy, Combination; Female; Humans; Interferon alpha-2; Interferon-alpha; Interferon-beta; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Suicide; Time Factors; Young Adult	2013
Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2014, Volume: 20 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Coronavirus; Coronavirus Infections; Critical Illness; Diabetes Mellitus; Female; Humans; Hypertension; Imipenem; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Renal Insufficiency, Chronic; Respiration, Artificial; Respiratory Tract Infections; Retrospective Studies; Ribavirin; Treatment Outcome; Young Adult	2014
Reply to "Chronic hepatitis C and diabetes: More questions than answers with the new direct acting antiviral drugs?". Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2016, Volume: 48, Issue:9 Topics: Antiviral Agents; Diabetes Mellitus; Hepatitis C, Chronic; Humans; Ribavirin	2016
Diabetes mellitus is associated with impaired response to antiviral therapy in chronic hepatitis C infection. Digestive diseases and sciences, 2009, Volume: 54, Issue:12 Topics: Adult; Antiviral Agents; Case-Control Studies; Diabetes Mellitus; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Hypoglycemic Agents; Insulin Resistance; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Odds Ratio; Ohio; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Assessment; Risk Factors; RNA, Viral; Severity of Illness Index; Time Factors; Treatment Failure; Viral Load	2009
Insulin resistance in HCV mono-infected and in HIV/HCV co-infected patients: Looking to the future. Journal of hepatology, 2009, Volume: 50, Issue:4 Topics: Antiviral Agents; Diabetes Mellitus; Hepatitis C, Chronic; HIV Infections; Humans; Insulin Resistance; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Predictive Value of Tests; Recombinant Proteins; Ribavirin; Risk Factors; Treatment Outcome; Viral Load	2009
Interferon-induced retinopathy and its risk in patients with diabetes and hypertension undergoing treatment for chronic hepatitis C virus infection. Alimentary pharmacology & therapeutics, 2009, Sep-15, Volume: 30, Issue:6 Topics: Adult; Aged; Antiviral Agents; Diabetes Mellitus; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Hypertension; Interferon alpha-2; Interferon-alpha; Interferons; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retinal Diseases; Retrospective Studies; Ribavirin; Risk Factors	2009
Hyalohyphomycosis caused by Paecilomyces lilacinus after kidney transplantation. Transplantation proceedings, 2009, Volume: 41, Issue:7 Topics: Antifungal Agents; Diabetes Mellitus; Female; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Interferons; Kidney Transplantation; Middle Aged; Mycoses; Paecilomyces; Polycystic Kidney Diseases; Postoperative Complications; Pyrimidines; Renal Replacement Therapy; Ribavirin; Treatment Outcome; Triazoles; Voriconazole	2009
Prevalence and impact of hepatic steatosis on the response to antiviral therapy in Saudi patients with genotypes 1 and 4 chronic hepatitis C. Digestive diseases and sciences, 2011, Volume: 56, Issue:4 Topics: Adult; Antiviral Agents; Biopsy; Body Mass Index; Diabetes Mellitus; Fatty Liver; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Hyperlipidemias; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prevalence; Recombinant Proteins; Retrospective Studies; Ribavirin; Saudi Arabia; Severity of Illness Index	2011
Is combination therapy interferon and ribavirin in patients with chronic hepatitis C infection toxic for eyes? Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2013, Volume: 29, Issue:3 Topics: Adult; Antiviral Agents; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Hypertension; Interferon alpha-2; Interferon-alpha; Logistic Models; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retinal Diseases; Ribavirin; Risk Factors	2013
Chronic viral hepatitis, interferon, diabetes mellitus, and celiac disease. The American journal of gastroenterology, 2003, Volume: 98, Issue:10 Topics: Adult; Celiac Disease; Diabetes Mellitus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Function Tests; Male; Prognosis; Ribavirin; Risk Assessment	2003
Development of reversible diabetes mellitus after cessation of interferon-alpha therapy for chronic hepatitis C infection. The New Zealand medical journal, 2004, Dec-17, Volume: 117, Issue:1207 Topics: Adult; Antiviral Agents; Autoimmune Diseases; Diabetes Mellitus; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Recombinant Proteins; Ribavirin	2004
Decline in haemoglobin A1c values in diabetic patients receiving interferon-alpha and ribavirin for chronic hepatitis C. Journal of viral hepatitis, 2006, Volume: 13, Issue:9 Topics: Antiviral Agents; Blood Glucose; Body Weight; Diabetes Complications; Diabetes Mellitus; Erythrocyte Indices; Female; Glycated Hemoglobin; Hemoglobins; Hepatitis C, Chronic; Humans; Interferon-alpha; L-Lactate Dehydrogenase; Male; Middle Aged; Reticulocyte Count; Retrospective Studies; Ribavirin	2006
Artificially low HbA1c associated with treatment with ribavirin. BMJ (Clinical research ed.), 2008, Mar-01, Volume: 336, Issue:7642 Topics: Antiviral Agents; Diabetes Mellitus; Glycated Hemoglobin; Hepatitis C, Chronic; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Ribavirin	2008